Asset Details
Do you wish to reserve the book?
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
Do you wish to request the book?
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
2021
Overview
Histone modification is aberrantly regulated in cancer and generates an unbalanced state of gene transcription. VprBP, a recently identified kinase, phosphorylates histone H2A on threonine 120 (T120) and is involved in oncogenic transcriptional dysregulation; however, its specific role in colon cancer is undefined. Here, we show that VprBP is overexpressed in colon cancer and directly contributes to epigenetic gene silencing and cancer pathogenesis. Mechanistically, the observed function of VprBP is mediated through H2AT120 phosphorylation (H2AT120p)‐driven transcriptional repression of growth regulatory genes, resulting in a significantly higher proliferative capacity of colon cancer cells. Our preclinical studies using organoid and xenograft models demonstrate that treatment with the VprBP inhibitor B32B3 impairs colonic tumor growth by blocking H2AT120p and reactivating a transcriptional program resembling that of normal cells. Collectively, our work describes VprBP as a master kinase contributing to the development and progression of colon cancer, making it a new molecular target for novel therapeutic strategies. VprBP is a recently identified kinase that induces transcriptional silencing of growth suppressive genes to cause cancer. In this study, we demonstrate that VprBP is overexpressed in colon cancer and drives tumorigenic transcription program through H2AT120 phosphorylation. VprBP‐mediated H2AT120 phosphorylation is functionally important, because blocking VprBP kinase activity impedes colonic tumor growth.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
